M Molloy1, R Comer2, P Rogers2, M Dowling3, P Meskell3, K Asbury2, M O'Leary2. 1. Women's and Children's Directorate, University Hospital, Newcastle Rd, Galway, Ireland. Maura.molloy@hse.ie. 2. Women's and Children's Directorate, University Hospital, Newcastle Rd, Galway, Ireland. 3. School of Nursing and Midwifery, National University of Ireland, University Road, Galway, Ireland.
Abstract
AIM: To determine the results of combined cytology and high-risk human papilloma virus (HR HPV) tests at 6 and 18 months postcolposcopy treatment at one Irish colposcopy centre. METHODS: All women who attended the centre's colposcopy smear clinic for a co-test 6 months (initial test) posttreatment were included in the audit (n = 251). RESULTS: The results revealed negative HR HPV for 79 % (n = 198) of women tested 6 months after treatment and positive results for 21 % (n = 53). HR HPV testing was more sensitive than cytology and led to early detection of residual disease. No women with negative HR HPV had high-grade cytology. CONCLUSION: HR HPV is more sensitive than cytology for detection of persistent CIN. However, 19 women with positive HR HPV had normal colposcopy with no persistent CIN detected. A national cost-benefit analysis is recommended to determine the value of the second co-test.
AIM: To determine the results of combined cytology and high-risk human papilloma virus (HR HPV) tests at 6 and 18 months postcolposcopy treatment at one Irish colposcopy centre. METHODS: All women who attended the centre's colposcopy smear clinic for a co-test 6 months (initial test) posttreatment were included in the audit (n = 251). RESULTS: The results revealed negative HR HPV for 79 % (n = 198) of women tested 6 months after treatment and positive results for 21 % (n = 53). HR HPV testing was more sensitive than cytology and led to early detection of residual disease. No women with negative HR HPV had high-grade cytology. CONCLUSION:HR HPV is more sensitive than cytology for detection of persistent CIN. However, 19 women with positive HR HPV had normal colposcopy with no persistent CIN detected. A national cost-benefit analysis is recommended to determine the value of the second co-test.
Entities:
Keywords:
Audit; Cervical intraepithelial neoplasia; Colposcopy; HPV DNA tests; Papanicolaou test
Authors: Marc Arbyn; Silvia de Sanjosé; Mona Saraiya; Mario Sideri; Joel Palefsky; Charles Lacey; Maura Gillison; Laia Bruni; Guglielmo Ronco; Nicolas Wentzensen; Julia Brotherton; You-Lin Qiao; Lynnette Denny; Jacob Bornstein; Laurent Abramowitz; Anna Giuliano; Massimo Tommasino; Joseph Monsonego Journal: Int J Cancer Date: 2012-07-02 Impact factor: 7.396
Authors: H C Kitchener; P G Walker; L Nelson; R Hadwin; J Patnick; G B Anthony; A Sargent; J Wood; C Moore; M E Cruickshank Journal: BJOG Date: 2008-05-22 Impact factor: 6.531
Authors: J Cuzick; P Sasieni; P Davies; J Adams; C Normand; A Frater; M van Ballegooijen; E van den Akker-van Marle Journal: Br J Cancer Date: 2000-09 Impact factor: 7.640
Authors: M A Nobbenhuis; C J Meijer; A J van den Brule; L Rozendaal; F J Voorhorst; E K Risse; R H Verheijen; T J Helmerhorst Journal: Br J Cancer Date: 2001-03-23 Impact factor: 7.640
Authors: Guglielmo Ronco; Joakim Dillner; K Miriam Elfström; Sara Tunesi; Peter J F Snijders; Marc Arbyn; Henry Kitchener; Nereo Segnan; Clare Gilham; Paolo Giorgi-Rossi; Johannes Berkhof; Julian Peto; Chris J L M Meijer Journal: Lancet Date: 2013-11-03 Impact factor: 79.321
Authors: Megan A Clarke; Elizabeth R Unger; Rosemary Zuna; Erin Nelson; Teresa M Darragh; Miriam Cremer; Colleen K Stockdale; Mark H Einstein; Nicolas Wentzensen Journal: J Low Genit Tract Dis Date: 2020-04 Impact factor: 3.842
Authors: Megan A Clarke; Teresa M Darragh; Erin Nelson; Elizabeth R Unger; Rosemary Zuna; Miriam Cremer; Colleen K Stockdale; Mark H Einstein; Nicolas Wentzensen Journal: J Low Genit Tract Dis Date: 2020-04 Impact factor: 3.842